<DOC>
	<DOCNO>NCT01870830</DOCNO>
	<brief_summary>The purpose study evaluate whether nocturnal breathing sleep patient chronic obstructive pulmonary disease ( COPD ) disturb stay moderate altitude .</brief_summary>
	<brief_title>Nocturnal Breathing Sleep Patients With Chronic Obstructive Pulmonary Disease Staying Altitude</brief_title>
	<detailed_description>This randomize cross-over trial evaluates hypothesis patient chronic obstructive pulmonary disease experience nocturnal hypoxemia , periodic breathe sleep disturbance stay moderate altitude . Sleep study clinical evaluation perform 2 day Zurich ( 490 , low altitude baseline ) 2 day Davos Clavadel ( 1650 ) , 2 day Davos Jakobshorn ( 2590 ) .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>chronic obstructive pulmonary disease ( COPD ) , GOLD grade 23 resident low altitude ( &lt; 800 ) Unstable condition , COPD exacerbation Mild ( GOLD 1 ) severe COPD ( GOLD 4 ) requirement oxygen therapy low altitude residence hypoventilation pulmonary hypertension mild unstable cardiovascular disease use drug affect respiratory center drive internal , neurologic psychiatric disease interfere protocol compliance include current heavy smoking ( &gt; 20 cigarette per day ) , inability perform 6 min walk test . previous intolerance moderate altitude ( &lt; 2600m ) . Exposure altitudes &gt; 1500m &gt; 2 day within last 4 week study . Pregnant nursing patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>